
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets
Jelle J. F. Sleeboom, Gilles S. van Tienderen, Katja Schenke‐Layland, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 728
Closed Access | Times Cited: 78
Jelle J. F. Sleeboom, Gilles S. van Tienderen, Katja Schenke‐Layland, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 728
Closed Access | Times Cited: 78
Showing 1-25 of 78 citing articles:
Dendritic Polymer‐Based Nanomedicines Remodel the Tumor Stroma: Improve Drug Penetration and Enhance Antitumor Immune Response
Yuxin Zhang, Zaixiang Fang, Dayi Pan, et al.
Advanced Materials (2024) Vol. 36, Iss. 25
Closed Access | Times Cited: 21
Yuxin Zhang, Zaixiang Fang, Dayi Pan, et al.
Advanced Materials (2024) Vol. 36, Iss. 25
Closed Access | Times Cited: 21
Clinical applications of human organoids
Monique M.A. Verstegen, Robert P. Coppes, Anne Béghin, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 8
Monique M.A. Verstegen, Robert P. Coppes, Anne Béghin, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 8
Radiopharmaceuticals and their applications in medicine
Siqi Zhang, Xingkai Wang, Xin Gao, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Siqi Zhang, Xingkai Wang, Xin Gao, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Invasion and metastasis in cancer: molecular insights and therapeutic targets
Yongxing Li, Fengshuo Liu, Qingjin Cai, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Yongxing Li, Fengshuo Liu, Qingjin Cai, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy
Xinyue Shao, Xiaoling Zhao, Binghao Wang, et al.
Theranostics (2025) Vol. 15, Iss. 5, pp. 1689-1714
Open Access | Times Cited: 2
Xinyue Shao, Xiaoling Zhao, Binghao Wang, et al.
Theranostics (2025) Vol. 15, Iss. 5, pp. 1689-1714
Open Access | Times Cited: 2
Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment
Die Lv, Yujie Fei, Hongli Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Die Lv, Yujie Fei, Hongli Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities
Bianca Garlisi, Sylvia Lauks, Caroline Aitken, et al.
Current Oncology (2024) Vol. 31, Iss. 7, pp. 3826-3844
Open Access | Times Cited: 11
Bianca Garlisi, Sylvia Lauks, Caroline Aitken, et al.
Current Oncology (2024) Vol. 31, Iss. 7, pp. 3826-3844
Open Access | Times Cited: 11
Targets of tumor microenvironment for potential drug development
Ling Zhang, Ziruoyu Wang, Kailu Liu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 10
Ling Zhang, Ziruoyu Wang, Kailu Liu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 10
Prediction of Clinically Significant Prostate Cancer by a Specific Collagen-related Transcriptome, Proteome, and Urinome Signature
Isabel Heidegger, Maria Frantzi, Stefan Salcher, et al.
European Urology Oncology (2024)
Closed Access | Times Cited: 8
Isabel Heidegger, Maria Frantzi, Stefan Salcher, et al.
European Urology Oncology (2024)
Closed Access | Times Cited: 8
Biomaterials to regulate tumor extracellular matrix in immunotherapy
Yujie Zhang, Xuexue Dong, Yanxiang Zhang, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 149-166
Closed Access | Times Cited: 8
Yujie Zhang, Xuexue Dong, Yanxiang Zhang, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 149-166
Closed Access | Times Cited: 8
Biomechanics in the tumor microenvironment: from biological functions to potential clinical applications
Hao Peng, Zheng Chao, Zefeng Wang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Hao Peng, Zheng Chao, Zefeng Wang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Fibrinogen: a new player and target on the formation of pre-metastatic niche in tumor metastasis
Yuxin Zhang, Zelin Li, Jiamao Zhang, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 207, pp. 104625-104625
Closed Access | Times Cited: 1
Yuxin Zhang, Zelin Li, Jiamao Zhang, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 207, pp. 104625-104625
Closed Access | Times Cited: 1
Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategies
D.Y. Luo, Jing Zhou, Shuiliang Ruan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
D.Y. Luo, Jing Zhou, Shuiliang Ruan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Effects of super-enhancers in cancer metastasis: mechanisms and therapeutic targets
Shenglan Liu, Wei Dai, Bei Jin, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Shenglan Liu, Wei Dai, Bei Jin, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts
De‐Zhen Guo, Xin Zhang, S Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
De‐Zhen Guo, Xin Zhang, S Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Glycogen synthase kinase-3: A potential immunotherapeutic target in tumor microenvironment
Jingyi Liang, Meng Yu, Yunong Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116377-116377
Open Access | Times Cited: 6
Jingyi Liang, Meng Yu, Yunong Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116377-116377
Open Access | Times Cited: 6
Alarmin S100A8 imparts chemoresistance of esophageal cancer by reprogramming cancer-associated fibroblasts
Xinjie Chen, Guoyu Cheng, Liang Zhu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 6, pp. 101576-101576
Open Access | Times Cited: 6
Xinjie Chen, Guoyu Cheng, Liang Zhu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 6, pp. 101576-101576
Open Access | Times Cited: 6
Biological significance and pathophysiological role of Matrix Metalloproteinases in the Central Nervous System
Krishnendu Ganguly, Krishnendu Adhikary, Arup Acharjee, et al.
International Journal of Biological Macromolecules (2024), pp. 135967-135967
Closed Access | Times Cited: 5
Krishnendu Ganguly, Krishnendu Adhikary, Arup Acharjee, et al.
International Journal of Biological Macromolecules (2024), pp. 135967-135967
Closed Access | Times Cited: 5
High matrix stiffness accelerates migration of hepatocellular carcinoma cells through the integrin β1-Plectin-F-actin axis
Zhihui Wang, Wenbin Wang, Qing Luo, et al.
BMC Biology (2025) Vol. 23, Iss. 1
Open Access
Zhihui Wang, Wenbin Wang, Qing Luo, et al.
BMC Biology (2025) Vol. 23, Iss. 1
Open Access
Extracellular matrix cancer‐associated fibroblasts promote stromal fibrosis and immune exclusion in triple‐negative breast cancer
Xun‐Xi Lu, Zongchao Gou, Hong Chen, et al.
The Journal of Pathology (2025)
Closed Access
Xun‐Xi Lu, Zongchao Gou, Hong Chen, et al.
The Journal of Pathology (2025)
Closed Access
Tumor-associated-fibrosis and active collagen-CD44 axis characterize a poor-prognosis subtype of gastric cancer and contribute to tumor immunosuppression
Yingqi Yang, Haohan Sun, Hongkai Yu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Yingqi Yang, Haohan Sun, Hongkai Yu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Early tolerance and late persistence as alternative drug responses in cancer
Simona Punzi, Davide Cittaro, Guido Gatti, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Simona Punzi, Davide Cittaro, Guido Gatti, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Prognostic impact of renin-angiotensin system inhibitors in patients with ovarian cancer: a meta-analysis of real-world evidence
Pian Wang, Xinmiao Zhang, Jinhai Shen
Expert Review of Anticancer Therapy (2025), pp. 1-9
Closed Access
Pian Wang, Xinmiao Zhang, Jinhai Shen
Expert Review of Anticancer Therapy (2025), pp. 1-9
Closed Access
Actin-Targeted Magnetic Nanomotors Mechanically Modulate the Tumor Mechanical Microenvironment for Cancer Treatment
Xing Fan, Haotian Chen, Yuan Li, et al.
ACS Nano (2025)
Closed Access
Xing Fan, Haotian Chen, Yuan Li, et al.
ACS Nano (2025)
Closed Access
Proteomic profiling reveals biological processes and biomarkers involved in the pathogenesis of occult breast cancer
Jingyi Zhang, Yidi Wang, Yu Liu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Jingyi Zhang, Yidi Wang, Yu Liu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access